Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2015, Issue -, Pages 1-20
Publisher
Hindawi Limited
Online
2015-01-30
DOI
10.1155/2015/513295
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dimethyl Fumarate (Tecfidera)
- (2014) Jineane V. Venci et al. ANNALS OF PHARMACOTHERAPY
- Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis
- (2014) F. Zhou et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- (2014) Arianna Sartori et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cutting Edge: Central Nervous System Plasmacytoid Dendritic Cells Regulate the Severity of Relapsing Experimental Autoimmune Encephalomyelitis
- (2014) S. L. Bailey-Bucktrout et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: IL-21 Is Not Essential for Th17 Differentiation or Experimental Autoimmune Encephalomyelitis
- (2014) J. M. Coquet et al. JOURNAL OF IMMUNOLOGY
- The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation
- (2014) W. Chen et al. JOURNAL OF IMMUNOLOGY
- Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease
- (2014) Sho Takizawa et al. JOURNAL OF NEUROIMMUNOLOGY
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Aaron E Miller et al. LANCET NEUROLOGY
- Alemtuzumab for relapsing-remitting multiple sclerosis
- (2014) Richard A Diaz et al. LANCET NEUROLOGY
- Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis
- (2014) Hans-Peter Hartung et al. Multiple Sclerosis Journal
- TOWER confirms the efficacy of oral teriflunomide in MS
- (2014) Aiden Haghikia et al. Nature Reviews Neurology
- HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia
- (2014) Grazia Locafaro et al. Journal of Immunology Research
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis
- (2013) Valérie Jolivel et al. BRAIN
- Vitamin D3Induces IDO+Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE
- (2013) Alessandro S. Farias et al. CNS Neuroscience & Therapeutics
- Gene expression analysis reveals functional pathways of glatiramer acetate activation
- (2013) Shlomo Bakshi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Treating multiple sclerosis with monoclonal antibodies: a 2013 update
- (2013) Annika Deiß et al. Expert Review of Neurotherapeutics
- Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity
- (2013) Fang Zhou et al. IMMUNOBIOLOGY
- Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis
- (2013) Rodolfo Thomé et al. IMMUNOLOGY AND CELL BIOLOGY
- Vitamin D and multiple sclerosis
- (2013) Sarah Hewer et al. JOURNAL OF CLINICAL NEUROSCIENCE
- IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis
- (2013) Wen Xu et al. JOURNAL OF NEUROIMMUNOLOGY
- The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
- (2013) Li Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
- (2013) M. Filippi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
- (2013) Ralf Gold et al. LANCET
- Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
- (2013) Heinz Wiendl et al. Nature Reviews Neurology
- Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy
- (2012) L. van de Laar et al. BLOOD
- Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE
- (2012) Magnus Isaksson et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients
- (2012) Dàlia Raϊch-Regué et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli
- (2012) Andrew J. Kassianos et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Dendritic Cells Ameliorate Autoimmunity in the CNS by Controlling the Homeostasis of PD-1 Receptor+ Regulatory T Cells
- (2012) Nir Yogev et al. IMMUNITY
- Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
- (2012) Haiyan Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source
- (2012) M. D. Leech et al. JOURNAL OF IMMUNOLOGY
- Immune Heterogeneity in Neuroinflammation: Dendritic Cells in the Brain
- (2012) Carol A. Colton Journal of Neuroimmune Pharmacology
- Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells
- (2012) Latt Latt Aung et al. JOURNAL OF NEUROIMMUNOLOGY
- Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis
- (2012) Sakhina Begum-Haque et al. JOURNAL OF NEUROIMMUNOLOGY
- Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis
- (2012) F. Sellebjerg et al. Multiple Sclerosis Journal
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis
- (2012) Clara de Andrés et al. PLoS One
- Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica
- (2012) Bernd C. Kieseier et al. JAMA Neurology
- Therapeutic potential of semi-mature dendritic cells for tolerance induction
- (2012) Manfred B. Lutz Frontiers in Immunology
- IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
- (2011) Cheryl M. Sweeney et al. BRAIN BEHAVIOR AND IMMUNITY
- Immune mechanisms of new therapeutic strategies in multiple sclerosis—A focus on alemtuzumab
- (2011) Luisa Klotz et al. CLINICAL IMMUNOLOGY
- Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis
- (2011) Roland Martin CLINICAL IMMUNOLOGY
- TH17 cytokines in autoimmune neuro-inflammation
- (2011) Burkhard Becher et al. CURRENT OPINION IN IMMUNOLOGY
- Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients
- (2011) Ghasem Mosayebi et al. IMMUNOLOGICAL INVESTIGATIONS
- Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells
- (2011) Jun-Min Li et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
- (2011) Kamran Ghoreschi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
- (2011) Niroshana Anandasabapathy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human Dendritic Cell Subsets from Spleen and Blood Are Similar in Phenotype and Function but Modified by Donor Health Status
- (2011) D. Mittag et al. JOURNAL OF IMMUNOLOGY
- Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: An ongoing story
- (2011) Ana Caminero et al. JOURNAL OF NEUROIMMUNOLOGY
- IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis
- (2011) Meiyue Chen et al. JOURNAL OF NEUROIMMUNOLOGY
- Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse
- (2011) Ana Longhini et al. Journal of Neuroinflammation
- Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
- (2011) S. Simpson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Insight into the mechanism of laquinimod action
- (2011) W. Brück et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
- (2011) Mohamed El-Behi et al. NATURE IMMUNOLOGY
- Window of opportunity for daclizumab
- (2011) Kimberly S Schluns NATURE MEDICINE
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Increase in Th17 and T-reg Lymphocytes and Decrease of IL22 Correlate with the Recovery Phase of Acute EAE IN Rat
- (2011) Beatriz Almolda et al. PLoS One
- Role of dendritic cells in the induction of regulatory T cells
- (2011) Rahul Kushwah et al. Cell and Bioscience
- CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system
- (2010) Carolin Prodinger et al. ACTA NEUROPATHOLOGICA
- Pathogenic mechanisms and experimental models of multiple sclerosis
- (2010) Anthony Slavin et al. AUTOIMMUNITY
- Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway
- (2010) S. Gregori et al. BLOOD
- Endothelial IL-1R1 is a critical mediator of EAE pathogenesis
- (2010) Qiming Li et al. BRAIN BEHAVIOR AND IMMUNITY
- Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
- (2010) Gerty Schreibelt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing–remitting multiple sclerosis
- (2010) Xin Zhang et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Estrogen receptor-β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease
- (2010) Sienmi Du et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Harnessing human dendritic cell subsets for medicine
- (2010) Hideki Ueno et al. IMMUNOLOGICAL REVIEWS
- Development of Dendritic Cell-Based Immunotherapy for Autoimmunity
- (2010) Catharien M. U. Hilkens et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice
- (2010) Andrew C. Melton et al. JOURNAL OF CLINICAL INVESTIGATION
- αv Integrin expression by DCs is required for Th17 cell differentiation and development of experimental autoimmune encephalomyelitis in mice
- (2010) Mridu Acharya et al. JOURNAL OF CLINICAL INVESTIGATION
- GM-CSF–dependent, CD103+dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization
- (2010) Irah L. King et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
- (2010) Sarah L. Jongbloed et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MHC class II–restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell–mediated autoimmunity
- (2010) Magali Irla et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An Imbalance of Two Functionally and Phenotypically Different Subsets of Plasmacytoid Dendritic Cells Characterizes the Dysfunctional Immune Regulation in Multiple Sclerosis
- (2010) N. Schwab et al. JOURNAL OF IMMUNOLOGY
- High-Grade Hydronephrosis Predicts Poor Outcomes After Radical Cystectomy in Patients with Bladder Cancer
- (2010) Dong Suk Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Plasmacytoid dendritic cells in multiple sclerosis: Chemokine and chemokine receptor modulation by interferon-beta
- (2010) Latt Latt Aung et al. JOURNAL OF NEUROIMMUNOLOGY
- Differential responses of human microglia and blood-derived myeloid cells to FTY720
- (2010) Bryce A. Durafourt et al. JOURNAL OF NEUROIMMUNOLOGY
- A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing–remitting or secondary progressive multiple sclerosis
- (2010) Timothy L Vollmer et al. Multiple Sclerosis Journal
- Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis
- (2010) Halina Bartosik-Psujek et al. Multiple Sclerosis Journal
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
- (2010) J. M. Burton et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis
- (2010) Hong-Liang Zhang et al. Neuroscience Bulletin
- Immunomodulatory effects of Vitamin D in multiple sclerosis
- (2009) J. Correale et al. BRAIN
- Modulation of natural killer cell cytotoxicity and cytokine release by the drug glatiramer acetate
- (2009) K. L. Sand et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE
- (2009) Magnus Isaksson et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-10: new perspectives on an old cytokine
- (2009) David M. Mosser et al. IMMUNOLOGICAL REVIEWS
- IFN- 1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation
- (2009) X. Zhang et al. JOURNAL OF IMMUNOLOGY
- Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy
- (2009) Mitosek-Szewczyk Krystyna et al. JOURNAL OF NEUROIMMUNOLOGY
- Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: A novel mechanism of AZA/6-MP
- (2009) Alessandra Aldinucci et al. JOURNAL OF NEUROIMMUNOLOGY
- Plasmacytoid Dendritic Cells in Multiple Sclerosis
- (2009) Roberto Lande et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Mitoxantrone and cytotoxic drugs' mechanisms of action
- (2009) T. Vollmer et al. NEUROLOGY
- Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab
- (2008) Maria del Pilar Martin ARCHIVES OF NEUROLOGY
- Imaging of plasmacytoid dendritic cell interactions with T cells
- (2008) M. Mittelbrunn et al. BLOOD
- Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation
- (2008) Gerald Brandacher et al. Current Opinion in Organ Transplantation
- IL‐21 and IL‐21R are not required for development of Th17 cells and autoimmunityin vivo
- (2008) Ivo Sonderegger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Determination of T-cell fate by dendritic cells
- (2008) Sandra S Diebold IMMUNOLOGY AND CELL BIOLOGY
- IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
- (2008) Stefan Haak et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-CD25 antibodies affect cytokine synthesis pattern of human dendritic cells and decrease their ability to prime allogeneic CD4+ T cells
- (2008) K. Mnasria et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis
- (2008) Adi Vaknin-Dembinsky et al. JOURNAL OF NEUROIMMUNOLOGY
- Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients
- (2008) Maddalena Ruggieri et al. JOURNAL OF NEUROIMMUNOLOGY
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
- (2008) Satoshi Serada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started